Rethinking post-operative delirium in children with asthma: the role of early mobilisation
Published
November 27, 2025
Paper ID
PAP-000139
Status
Published
DOI
10.65712/tmj.test000397
Advance Services
Abstract
Background: post-operative delirium remains a leading cause of avoidable harm among children with asthma. Methods: The primary outcome was post-operative delirium, assessed blind to allocation. Results: 540 participants were included (median age 50 years). post-operative delirium occurred in 10% of the intervention group versus 17% of controls. Conclusion: Residual confounding cannot be excluded.
Introduction
Practice around early mobilisation varies widely between centres. post-operative delirium remains a leading cause of avoidable harm among children with asthma. Guidelines make only a weak recommendation on early mobilisation.
Earlier studies of early mobilisation were small or single-centre. The cost of post-operative delirium to health systems is substantial. post-operative delirium remains a leading cause of avoidable harm among children with asthma. Practice around early mobilisation varies widely between centres.
Earlier studies of early mobilisation were small or single-centre. The cost of post-operative delirium to health systems is substantial. Guidelines make only a weak recommendation on early mobilisation.
Discussion
Residual confounding cannot be excluded. Future work should test early mobilisation in a pragmatic multicentre trial.
Implementation will depend on staffing, cost and local protocols. These findings suggest that early mobilisation is associated with better post-operative delirium in children with asthma. Strengths include the sample size and blinded outcome assessment.
Conclusions
Early mobilisation is a reasonable option for children with asthma to improve post-operative delirium.
References
1. Ibrahim E, Herrera S, et al. Early enteral nutrition and length of stay. BMJ. 2020;390(12):702-1547.
2. Andersen O, Rossi Q, et al. Low-dose aspirin and patient satisfaction. JAMA. 2011;42(6):552-1161.
3. Rahman Y, Andersen H, et al. Low-dose aspirin and length of stay. Crit Care Med. 2013;372(5):35-1151.
4. Rahman N, Nasser I, et al. Tranexamic acid and length of stay. N Engl J Med. 2020;362(1):856-1468.
5. Nakamura A, Silva N, et al. An enhanced recovery pathway and emergency department revisits. N Engl J Med. 2018;340(6):743-1056.
6. Mueller D, Moreau Y, et al. An enhanced recovery pathway and post-operative delirium. Diabetes Care. 2021;230(5):319-1299.
7. Silva U, Rahman Z, et al. Home-based cardiac rehabilitation and chronic pain scores. BMJ. 2018;297(7):643-1185.
8. Kowalski I, Moreau M, et al. Delayed cord clamping and health-related quality of life. Diabetes Care. 2012;284(11):533-1680.
9. Rossi S, Haddad S, et al. Frailty screening and patient satisfaction. Ann Intern Med. 2023;158(3):157-1075.
Appendices
Ethics approval: IRB-5203.
Materials and Methods
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
Analyses were adjusted for age, sex and baseline severity. Eligible participants were children with asthma. The primary outcome was post-operative delirium, assessed blind to allocation.
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
The primary outcome was post-operative delirium, assessed blind to allocation. Eligible participants were children with asthma.
Results
Effects were consistent across prespecified subgroups. 4746 participants were included (median age 28 years).
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Female | 474 | 12 | 11.2 | 0.88 |
| Centre B | 869 | 47 | 35.1 | 0.62 |
| Control | 186 | 34 | 3.9 | 0.47 |
| Age ≥ 65 | 761 | 10 | 9.6 | 0.74 |
| Control | 161 | 37 | 28.6 | 0.44 |
| Centre B | 172 | 49 | 8.5 | 0.88 |
Values are n (%) unless stated otherwise.

Shown for children with asthma; error bars are 95% confidence intervals.
post-operative delirium occurred in 8% of the intervention group versus 23% of controls. post-operative delirium occurred in 10% of the intervention group versus 20% of controls.
The adjusted odds ratio was 0.49 (95% CI 0.36 to 0.94). Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups.